1Y Close · As of Aug 26, 2026
CHONGKUNDANG HOLDINGS operates in the Pharmaceuticals sector.
Legal name: CHONGKUNDANG HOLDINGS CORP.
In fiscal year 2025, CHONGKUNDANG HOLDINGS (001630) reported revenue of 959.0 billion KRW, up 0.1% from 957.8 billion KRW a year earlier.
Operating profit was 58.3 billion KRW and net income was 54.3 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 196.4 billion KRW, with a P/B of 0.22.
These figures can be verified in the DART filing (receipt no. 20260318001530).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 959.0B | 58.3B | 54.3B |
| 2024 | 957.8B | 35.5B | 40.3B |
| 2023 | 879.8B | 17.0B | 40.6B |
Recent Filings
Material Business Matters (Subsidiary Material Matters)
Semi-Annual Report (2026.06)
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Material Business Matters (Subsidiary Material Matters) |
| 2026-08-14 | Semi-Annual Report (2026.06) |